Cargando…
Systemic inflammation response index (SIRI) predicts prognosis in hepatocellular carcinoma patients
The systemic inflammation response index (SIRI) is a useful tool for predicting prognosis in some types of cancer. In this retrospective study, we evaluated the efficacy of SIRI in predicting overall survival in hepatocellular carcinoma (HCC) patients following local or systemic therapy. A cutoff va...
Autores principales: | Xu, Litao, Yu, Shulin, Zhuang, Liping, Wang, Peng, Shen, Yehua, Lin, Junhua, Meng, Zhiqiang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5471025/ https://www.ncbi.nlm.nih.gov/pubmed/28430597 http://dx.doi.org/10.18632/oncotarget.16865 |
Ejemplares similares
-
Role of monocyte-to-lymphocyte ratio in predicting sorafenib response in patients with advanced hepatocellular carcinoma
por: Zhu, Zhenfeng, et al.
Publicado: (2018) -
The Predictive Role of Systemic Inflammation Response Index (SIRI) in the Prognosis of Stroke Patients
por: Zhang, Yihui, et al.
Publicado: (2021) -
Overexpression of a Long Non-Coding RNA BC037916 is Associated with Pancreatic Tumorigenesis and Poor Prognosis
por: Chen, Gang, et al.
Publicado: (2021) -
Serum miR-128-2 Serves as a Prognostic Marker for Patients with Hepatocellular Carcinoma
por: Zhuang, Liping, et al.
Publicado: (2015) -
ARHGAP4 mediates the Warburg effect in pancreatic cancer through the mTOR and HIF-1α signaling pathways
por: Shen, Yehua, et al.
Publicado: (2019)